November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario
May 21, 2024, 04:55

Jayastu Senapati: Optimal use of Azacytidine Venetoclax in AML Patients in Indian Scenario

Jayastu Senapati, Assistant Professor of Leukemia at MD Anderson Cancer Center, shared a post on X:

“Looking forward to discussing the optimal use of Hypomethylating Agent (HMA) – Venetoclax in patients with Acute Myeloid Leukaemia (AML), focussing on Indian/Low and Middle-Income Country (LMIC) settings- May 17, CT 8:30AM (IST 7PM).”

Additional information.
Source: Jayastu Senapati/X